Vaccine-induced allo-hla-reactive memory T cells in a kidney transplantation candidate

Transplantation

Volumn 91, Issue 6, 2011, Pages 645-651

  D'Orsogna, Lloyd J A ^a   Van Besouw, Nicole M ^b   Van Der Meer Prins, Ellen M W ^a   Van Der Pol, Pieter ^a   Franke Van Dijk, Marry ^a   Zoet, Yvonne M ^a   Van Der Slik, Arno ^a   Weimar, Willem ^b   Van Kooten, Cees ^a   Mulder, Arend ^a   Roelen, Dave L ^a   Doxiadis, Ilias I N ^a   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Alloreactivity; Heterologous immunity; Memory T cells; Vaccine; VZV

Indexed keywords

CD8 ANTIGEN; CHICKENPOX VACCINE; CYTOKINE; GAMMA INTERFERON; HLA B ANTIGEN; LIVE VACCINE; PHYTOHEMAGGLUTININ;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELL SELECTION; CELL STRAIN K 562; CONTROLLED STUDY; CROSS REACTION; CYTOKINE PRODUCTION; CYTOTOXICITY TEST; EFFECTOR CELL; HLA TYPING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOSTIMULATION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE CELL; LYMPHOCYTE CLONE; MEMORY T LYMPHOCYTE; MOLECULAR MECHANICS; PRIORITY JOURNAL; TARGET CELL; TISSUE SPECIFICITY; UMBILICAL VEIN ENDOTHELIAL CELL; VARICELLA ZOSTER VIRUS;

CHICKENPOX VACCINE; CROSS REACTIONS; CYTOTOXICITY, IMMUNOLOGIC; HLA ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOLOGIC MEMORY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; ORGAN SPECIFICITY; T-LYMPHOCYTES; TRANS-ACTIVATORS; VIRAL ENVELOPE PROTEINS;

EID: 79952764290     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318208c071     Document Type: Article

References (34)

1. Amir A, D'Orsogna L, Roelen D, et al. Allo-HLA reactivity of viral specific memory T-cells is common. Blood 2010; 115: 3146.
2. Adams A, Williams M, Jones T, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887.
3. Brook M, Wood K, Jones N. The impact of memory T-cells on rejection and the induction of tolerance. Transplantation 2006; 82: 1.
4. Selin L, Brehm M. Frontiers in nephrology: Heterologous immunity, T cell cross reactivity and alloreactivity. J Am Soc Nephrol 2007; 18: 2268.
5. Welsh R, Selin L. No one is naïve: The significance of heterologous T-cell immunity. Nat Rev Immunol 2002; 2: 417.
6. Yang H, Welsh R. Induction of alloreactive cytotoxic T cells by acute virus infection of mice. J Immunol 1986; 136: 1186.
7. Brehm M, Daniels K, Priyadharshini B, et al. Allografts stimulate crossreactive virus-specific memory CD8 T-cells with private specificity. Am J Transplant 2010; 10: 1738.
8. Webb S, Sprent J. T-cells with multiple specificities. Int Rev Immunol 1986; 1: 151.
9. Burrows S, Khanna R, Burrows J, et al. An alloresponse in humans is dominated by cytotoxic T-lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: Implications for graft-vs-host disease. J Exp Med 1994; 179: 1155.
10. Macdonald W, Chen Z, Gras S, et al. T cell recognition via molecular mimicry. Immunity 2009; 31: 897.
11. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004; 4: 160.
12. Avery R, Michaels M. Update on immunizations in solid organ transplant recipients: What clinicians need to know. Am J Transplant 2008; 8: 9.
13. Danziger-Isakov L, Cherkassky L, Siegel H, et al. Effects of influenza immunization on humoral and cellular alloreactivity in humans. Transplantation 2010; 89: 838.
14. Fehr T, Bossart W, Wahl C, et al. Disseminated varicella infection in adult renal allograft recipients: Four cases and a review of the literature. Transplantation 2002; 73: 608.
15. Geel A, Zuidema T, van Gelder T, et al. Successful vaccination against varicella zoster virus prior to kidney transplantation. Transplant Proc 2005; 37: 952.
16. Umetsu D, Yunis E, Matsui Y, et al. HLA-DR4-associated alloreactivity of an HLA-DR3-restricted tetanus toxoid-specific T-cell clone: Inhibition of both reactivities by an alloantiserum. Eur J Immunol 1985; 15: 356.
17. Nardone A, de Ory F, Carton M, et al. The comparative sero-epidemiology of varicella zoster virus in 11 countries in the European region. Vaccine 2007; 25: 7866.
18. de Melker H, Berbers G, Hahne S, et al. The epidemiology of varicella and herpes zoster in the Netherlands: Implications for varicella zoster virus vaccination. Vaccine 2006; 24: 3946.
19. Arvin A, Sharp M, Smith S, et al. Equivalent recognition of a varicellazoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T-lymphocytes of either CD4- or CD8- phenotype. J Immunol 1991; 146: 257.
20. Frey C, Sharp M, Min A, et al. Identification of CD8- T-cell epitopes in the immediate early 62 protein (IE62) of varicella-zoster virus, and evaluation of frequency of CD8- T-cell response to IE62, by use of IE62 peptides after varicella vaccination. J Infect Dis 2003; 188: 40.
21. van der Heiden P, de Boer R, van der Steen D, et al. Identification of varicella-zoster virus-specific CD8 T cells in patients after T-celldepleted allogeneic stem cell transplantation. J Virol 2009; 83: 7361.
22. Yi-qun Z, van Neervan J, Kasran A, et al. Differential requirements for co-stimulatory signals from B7 family members by resting versus recently activated memory T-cells towards soluble recall antigens. Int Immunol 1996; 8: 37.
23. Flynn K, Mullbacher A. Memory alloreactive cytotoxic T cells do not require costimulation for activation in vitro. Immunol Cell Biol 1996; 74: 413.
24. Allam A, Conze D, Torchia M, et al. The CD8- memory T-cell state of readiness is actively maintained and reversible. Blood 2009; 114: 2121.
25. Gray D, Matzinger P. T cell memory is short lived in the absence of antigen. J Exp Med 1991; 174: 969.
26. D'Orsogna L, Amir A, Zoet Y, et al. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire. Tissue Antigens 2009; 74: 290.
27. Zoet Y, Eijsink C, Kardol M, et al. The single antigen expressing lines (SALs) concept: An excellent tool for screening for HLA-specific antibodies. Hum Immunol 2005; 66: 519.
28. Woltman A, De Haij S, Boonstra J, et al. Interleukin-17 and CD40-ligand synergistically enhance cytokine and chemokine production by renal epithelial cells. J Am Soc Nephrol 2000; 11: 2044.
29. van Kooten C, Gerritsma J, Paape M, et al. Possible role for the CD40-CD40L in the regulation of interstitial infiltration in the kidney. Kidney Int 1997; 51: 711.
30. Miltenburg A, Meijer-Paape M, Daha M, et al. Donor-specific lysis of human proximal tubular epithelial cells by renal allograft-infiltrating lymphocytes. Transplantation 1989; 48: 296.
31. van der Woude F, Daha M, Miltenburg A, et al. Renal allograft-infiltrated lymphocytes and proximal tubular cells: Further analysis of donor-specific lysis. Hum Immunol 1990; 28: 186.
32. Maciag T, Hoover G, Stemerman M, et al. Serial propagation of human endothelial cells in vitro. J Cell Biol 1981; 91: 420.
33. Gordon P, Sussman I, Hatcher V. Long-term culture of human endothelial cells. In vitro 1983; 19: 661.
34. Jin Y, Jindra P, Gong K, et al. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation 2005; 79: S19.